㰀栀琀洀氀㸀 
㰀氀椀渀欀 爀攀氀㴀∀猀琀礀氀攀猀栀攀攀琀∀ 琀礀瀀攀㴀∀琀攀砀琀⼀挀猀猀∀ 栀爀攀昀㴀∀猀琀礀氀攀⸀挀猀猀∀⼀㸀 
㰀戀漀搀礀㸀 
Centre de Référence des Rhumatismes Inflammatoires et Maladies Autoimmunes Systémiques Rares de l’Enfant (RAISE) / 2017 
 
65 
onset spondylarthropathies. Ann 
Rheum Dis, 2002, 61 : 941-2 
Céspedes-Cruz 
Loy 
A, 
Murray 
KJ, 
Methotrexate 
health-related 
Foster 
LR, 
British Society for Paediatric and Adolescent 
Autologous 
Rheumatology. 
haematopoeitic 
stem severe 
rheumatic 
disease 
members--executive 
summary. 
Rheumatology 
(Oxford). 
Dec;45(12):1570–1.  2006 
García-Carrasco 
M, 
Alexandro 
RO, 
Rojas-Rodriguez J, Escobar LE. Efficacy 
systemic 
of 
thalidomide 
Bone 
Spine. 2007 Oct;74(5):500–3.  Gattorno 
Lasigliè 
D, Tassi S, Brisca G, Carta S, et al. anti-interleukin-1 
treatment 
distinguishes 
patients 
juvenile 
Arthritis 
with 
idiopathic 
Rheum. 
May;58(5):1505–15.  Gerloni 
Gattinara 
M, Arnoldi C, Pontikaki I, Fantini F. of 
cyclosporin A in the treatment of juvenile 
chronic 
prospective 
study. 
Rheumatology (Oxford). 2001 
Aug;40(8):907–13.  
Haapasaari 
Hakala 
M. 
antirheumatic drug therapy in 
the 
treatment 
of 
Rheumatol. 
Apr;20(2):259.  
2002 
Horneff 
Foeldvari 
De 
Safety 
efficacy 
to 
idiopathic 
preliminary 
arthritis 
(JIA): 
data 
Rheum 
2009 
Horneff G, Burgos-Vargas R, 
Constantin 
Rheum 
Dis. 
;73(6):1114-22. 
 
4. 
Horneff G, Fitter S, Foeldvari I et al Double-blind, placebo- 
 
Ther. 
24;14(5):R230